| 1 |
32997351 | Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients. | 2021 Apr |
1 |
| 2 |
33875422 | Pharmacogene Sequencing of a Gabonese Population with Severe Plasmodium falciparum Malaria Reveals Multiple Novel Variants with Putative Relevance for Antimalarial Treatment. | 2021 Jun 17 |
1 |
| 3 |
32864162 | Pharmacogenomics of COVID-19 therapies. | 2020 |
1 |
| 4 |
27618912 | Pathway-specific inhibition of primaquine metabolism by chloroquine/quinine. | 2016 Sep 13 |
3 |
| 5 |
12756207 | In vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation. | 2003 Jun |
3 |
| 6 |
10848718 | Influence of hydroxychloroquine on the bioavailability of oral metoprolol. | 2000 Jun |
2 |
| 7 |
9764961 | Chloroquine modulation of specific metabolizing enzymes activities: investigation with selective five drug cocktail. | 1998 Sep |
2 |
| 8 |
10896408 | Halofantrine and chloroquine inhibit CYP2D6 activity in healthy Zambians. | 1998 Mar |
3 |
| 9 |
8730982 | Lack of effect of chloroquine on the debrisoquine (CYP2D6 and S-mephenytoin (CYP2C19) hydroxylation phenotypes. | 1996 Apr |
2 |
| 10 |
8896943 | Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements. | 1996 Oct |
1 |